emc accessibility

eMC Accessibility

emc accessibility ensures that Pharma fulfil their requirements that partially sighted or blind people have access to patient information leaflets.

European Directive 2004/27/EC, Article 56a, states that Pharma companies must make Patient Information Leaflets (PILs) available in formats suitable for blind or visually impaired people. This embraces providing PILs in hardcopy large print, Braille and audio formats.

emc accessibility gives pharmaceutical companies a flexible, quick and cost-effective way of meeting those requirements; PILs that are included on emc are converted into a standard digitised structure (the X-PIL) which is then made available in various formats:

Via phone – patients can listen to the automated emc accessibility medicines information line where the PIL is read out in whole or by sections.

Via the web – X-PILs are available through the emc website where they can be viewed, or listened to using screen reader software.

Hard-copy (inc. braille) –  PILs can also be ordered in large print, Braille, or audio CD which are supplied by the Royal National Institute of Blind People (RNIB).

Pharma companies simply upload PILs to emc and Datapharm take care of the rest.


If you’d like to find out more information, please fill in the form below and one of our representatives will be in touch shortly.

Datapharm Limited collects personal information when you enquire with us about our products and services using the above form. We will use this information to provide the services and/or information requested, and if you agree, to send you marketing information. Datapharm Ltd will not share your information with third party companies. We will not hold information for longer than is deemed necessary. For more information explaining how we use your information please see our privacy policy.

I consent to Datapharm Ltd holding the above data about me in order to provide me with the information/services I have requested above:


I consent to Datapharm Ltd holding the above data about me in order to provide me with future marketing information in relation to the products and services offered by Datapharm: